Your browser doesn't support javascript.
loading
SEOM clinical guideline on unknown primary cancer (2017).
Losa, F; Soler, G; Casado, A; Estival, A; Fernández, I; Giménez, S; Longo, F; Pazo-Cid, R; Salgado, J; Seguí, M Á.
Affiliation
  • Losa F; Hospital de Sant Joan Despí Moisés Broggi, Sant Joan Despí, Barcelona, Spain. ferran.losa@sanitatintegral.org.
  • Soler G; Hospital Durán i Reynals (ICO-L'Hospitalet), Barcelona, Spain.
  • Casado A; Hospital Universitario Clínico San Carlos, Madrid, Spain.
  • Estival A; Hospital Universitari Germans Trias i Pujol, Barcelona, Spain.
  • Fernández I; Hospital Alvaro Cunqueiro-Complejo Hospitalario Universitario, Vigo, Spain.
  • Giménez S; Hospital Universitari I Politècnic la Fe, Valencia, Spain.
  • Longo F; Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Pazo-Cid R; Hospital Universitario Miguel Servet, Zaragoza, Spain.
  • Salgado J; Complejo Hospitalario de Navarra, Pamplona, Spain.
  • Seguí MÁ; Parc Taulí Sabadell, Hospital Universitari, Sabadell, Barcelona, Spain.
Clin Transl Oncol ; 20(1): 89-96, 2018 Jan.
Article in En | MEDLINE | ID: mdl-29230692
Cancer of unknown primary site is a histologically confirmed cancer that manifests in advanced stage, with no identifiable primary site following standard diagnostic procedures. Patients are initially categorized based on the findings of the initial biopsy: adenocarcinoma, squamous-cell carcinoma, neuroendocrine carcinoma, and poorly differentiated carcinoma. Appropriate patient management requires understanding several clinical and pathological features that aid in identifying several subsets of patients with more responsive tumors.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplasms, Unknown Primary Type of study: Guideline / Prognostic_studies Limits: Humans Language: En Journal: Clin Transl Oncol Year: 2018 Document type: Article Affiliation country: Spain Country of publication: Italy

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplasms, Unknown Primary Type of study: Guideline / Prognostic_studies Limits: Humans Language: En Journal: Clin Transl Oncol Year: 2018 Document type: Article Affiliation country: Spain Country of publication: Italy